| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 06/28/2001 | WO2001046415A1 Novel tachykinin-like polypeptides and use thereof |
| 06/28/2001 | WO2001046414A1 Novel guanosine triphosphate-binding protein-coupled receptor protein, bg26 |
| 06/28/2001 | WO2001046408A2 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | WO2001046400A1 MODIFIED α-1,2-FUCOSYLTRANSFERASE GENE AND PROCESS FOR PRODUCING α-1,2-FUCOSYLTRANSFERASE AND FUCOSE-CONTAINING SUGAR CHAIN |
| 06/28/2001 | WO2001046398A2 Aspartyl proteases |
| 06/28/2001 | WO2001046397A2 Human kinases |
| 06/28/2001 | WO2001046396A1 Rna polymerases from bacteriophage phi 6-phi 14 and use thereof |
| 06/28/2001 | WO2001046394A2 Mammalian protein phosphatases |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046266A1 Macroporous chitosan beads and preparation method thereof |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046254A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046233A1 Receptor-like protein kinases from nicotiana tabacum |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046226A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001046224A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/28/2001 | WO2001045730A2 Tweak receptor |
| 06/28/2001 | WO2001045721A1 Agent which is anti-adhesive in relation to the pathogenic flora of the skin |
| 06/28/2001 | WO2001005961B1 Recombinase-based methods for producing expression vectors and compositions for use in practicing the same |
| 06/28/2001 | WO2001004148A3 Donor strand complemented pilin and adhesin broad-based vaccines |
| 06/28/2001 | WO2000078322A3 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 06/28/2001 | WO2000077186A3 Bacterial protection against stress |
| 06/28/2001 | WO2000075324A3 Recombinant prion-like genes and proteins and materials and methods comprising same |
| 06/28/2001 | WO2000075305A3 Candida albicans genes and proteins coded by said genes |
| 06/28/2001 | WO2000073462A3 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
| 06/28/2001 | WO2000073344A3 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 06/28/2001 | WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 06/28/2001 | WO2000071741A3 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000068247A3 Serine proteases |
| 06/28/2001 | WO2000066731A3 Recombinant laminin 5 |
| 06/28/2001 | WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000055321A3 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO2000044774A3 Inhibition of stat3 signal transduction for human cancer therapy |
| 06/28/2001 | WO2000027437A9 Polymer grafting by polysaccharide synthases |
| 06/28/2001 | WO1999064461A9 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 06/28/2001 | WO1999046575A3 Peptides containing a cholesterol recognition sequence and their uses |
| 06/28/2001 | WO1997046686A3 Tumor necrosis factor-related polypeptide |
| 06/28/2001 | US20010005750 Fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising carbon, nitrogen and mineral salt sources, cultivation is carried out by addition of organic carbon source by oscillation feed |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | DE10059107A1 Extract of blue alga with high magnesium content, useful for dermatological or cosmetic treatment of skin and hair, stimulates synthesis of adenosine triphosphate and matrix proteins |
| 06/28/2001 | CA2395714A1 Novel tachykinin-like polypeptides and use thereof |
| 06/28/2001 | CA2395525A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2395369A1 Cytokine zcyto18 |
| 06/28/2001 | CA2395286A1 Aspartyl proteases |
| 06/28/2001 | CA2395269A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | CA2395245A1 Macroporous chitosan beads and preparation method thereof |
| 06/28/2001 | CA2395239A1 Rna polymerases from bacteriophage phi 6-phi 14 and use thereof |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395102A1 Human kinases |
| 06/28/2001 | CA2395076A1 Modified .alpha.-1,2-fucosyltransferase gene and process for producing .alpha.-1,2-fucosyltransferase and fucose-containing sugar chain |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2394015A1 Tweak receptor |
| 06/28/2001 | CA2393855A1 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | CA2393500A1 Methods and compositions for detecting hepatitis e virus |
| 06/28/2001 | CA2392827A1 Double selection vector |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2391594A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2329676A1 Salmonella vaccine |
| 06/27/2001 | EP1111062A1 Nucleotide sequences encoding the gene zwa1 |
| 06/27/2001 | EP1111061A1 Double selection vector |
| 06/27/2001 | EP1111060A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 06/27/2001 | EP1111059A1 A novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
| 06/27/2001 | EP1111058A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 06/27/2001 | EP1111056A2 Process for activating a kinase |
| 06/27/2001 | EP1111054A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/27/2001 | EP1111052A1 Novel gene |
| 06/27/2001 | EP1111051A1 Promoter for guard cell-specific gene expression in plants |
| 06/27/2001 | EP1111050A2 Human procalcitonin, its production and use |
| 06/27/2001 | EP1111049A1 Novel receptor protein and method for diagnosing inflammatory diseases by using the same |
| 06/27/2001 | EP1111047A2 Novel protein and dna thereof |
| 06/27/2001 | EP1110970A1 Anti-Procalcitonin antibody, their production and use |
| 06/27/2001 | EP1110555A1 Antiadhesive agent for the pathogen flora of the skin |
| 06/27/2001 | EP1109928A1 Enzymatic oxidative deamination process |
| 06/27/2001 | EP1109922A1 Method for the production of heterologous polypeptides in transformed yeast cells |
| 06/27/2001 | EP1109920A1 Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity |
| 06/27/2001 | EP1109919A2 Rationally designed heparinases derived from heparinase i and ii |
| 06/27/2001 | EP1109918A2 Polypeptides, polynucleotides and uses thereof |
| 06/27/2001 | EP1109916A1 Nucleic acid molecules encoding an amylosucrase |
| 06/27/2001 | EP1109915A1 Nucleotide sequences for the tal gene |
| 06/27/2001 | EP1109913A1 Nucleotide sequences which code for the opca gene |
| 06/27/2001 | EP1109912A1 Phenolic acid esterases, coding sequences and methods |
| 06/27/2001 | EP1109911A2 Staphylococcus aureus genes and polypeptides |
| 06/27/2001 | EP1109907A1 Human cell junction pdz protein |
| 06/27/2001 | EP1109905A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 06/27/2001 | EP1109904A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109895A1 Endothelial cell proliferation inhibitors derived from human prothrombin |
| 06/27/2001 | EP1109894A1 Recombinant vanadium haloperoxidases and their uses |
| 06/27/2001 | EP1109886A1 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity |
| 06/27/2001 | EP1109833A2 Compositions and methods for the treatment of tumors |
| 06/27/2001 | EP1109831A2 Cyctotoxic peptides modified by bulky or lipophilic moieties |
| 06/27/2001 | EP1109829A1 Human latent transforming growth factor beta binding protein 3 |